Nanosphere, Inc.
Adding one more nanotech stock to the list: Nanosphere, Inc. (NASDAQ: NSPH)
As in Google Finance description:
Nanosphere, Inc. is engaged on developing, manufacturing and marketing a molecular diagnostics platform, the Verigene System, that enables genomic and protein testing on a single platform. The Company’s nanoparticle technology seeks to simplify the ability to perform molecular diagnostic tests, achieve ultra-sensitive protein detection, provide the ability to multiplex, or run multiple tests at the same time on the same sample, and to enable the development of test assays to be performed on a single platform. Nanosphere is developing diagnostic tests for a variety of medical conditions including cancer, neurodegenerative, cardiovascular and infectious diseases, as well as pharmaco-genomics, or tests for personalized medicine.
Even if this nanotech stock recovered from it's lows back in March, it still looks Bearish, with a very light volume, remember this is still a Micro-Cap Company.
Some Nanosphere recent news:
Nanosphere to Release Three Abstracts At American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
Nanosphere Announces First Quarter 2009 Results
Extreme FDA Trades on Pending FDA Medical Device Decisions for (OTC:NEPH), (AMEX:BVX) and (NASDAQ:NSPH)
Labels: Nanoanalysis, Nanosphere Inc., nanotech, Nanotech stocks, nanotechstocks, NSPH